Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update

Literals

• bibo:eissn
  • 1532-6535
• dcterms:contributor
  • Karnes J.H. et al.
• dcterms:creator
  • Karnes J.H.
• bibo:doi
  • 10.1002/cpt.2008
• ou:tipoPublicacion
  • Review
• fabio:hasPublicationYear
  • 2021
• ou:eid
  • 2-s2.0-85090156780
• vivo:identifier
  • 2021-1308
• bibo:issn
  • 0009-9236
• bibo:page_range
  • 302-309
• dcterms:publisher
  • Clinical Pharmacology and Therapeutics
• dcterms:title
  • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update
• vcard:url
  • https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85090156780&origin=inward
• ou:urlScopus
  • https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85090156780&origin=inward
• bibo:volume
  • 109

Typed Literals

• ou:vecesCitado
  • 118 (xsd:integer)

Relations

• ou:publicadaEnRevista
  • CLINICAL PHARMACOLOGY & THERAPEUTICS
  • Clinical Pharmacology and Therapeutics

Inverse Relations

• Has related: ou:tienePublicacion
  • ADRIÁN LLERENA RUIZ